Exploring the potential public health benefits of universal influenza vaccine

References

• Scorza FB, Tsvetnitsky V, Donnelly JJ. Universal influenza vaccines: shifting to better vaccines. Vaccine. 2016;34(26):2926–33. doi:10.1016/j.vaccine.2016.03.085.
   PubMed Web of Science ®Google Scholar
• Johnson DR, Nichol KL, Lipczynski K. Barriers to adult immunization. Am J Med. 2008;121(7):S28–S35. doi:10.1016/j.amjmed.2008.05.005.
   PubMed Web of Science ®Google Scholar
• Taddio A, Ipp M, Thivakaran S, Jamal A, Parikh C, Smart S, Sovran J, Stephens D, Katz J. Survey of the prevalence of immunization non-compliance due to needle fears in children and adults. Vaccine. 2012;30(32):4807–12. doi:10.1016/j.vaccine.2012.05.011.
   PubMed Web of Science ®Google Scholar
• Seasonal flu vaccination: why don’t more Americans get it? [accessed 2018 Feb 15]. https://www.rand.org/content/dam/rand/pubs/research_briefs/2011/RAND_RB9572.pdf.
   Google Scholar
• Seale H, Heywood AE, McLaws M-L, Ward KF, Lowbridge CP, Van D, MacIntyre CR. Why do I need it? I am not at risk! Public perceptions towards the pandemic (H1N1) 2009 vaccine. BMC Infect Dis. 2010;10(1):99. doi:10.1186/1471-2334-10-99.
   PubMed Web of Science ®Google Scholar
• Uscher-Pines L, Maurer J, Kellerman A, Harris KM. Healthy young and middle age adults: what will it take to vaccinate them for influenza? Vaccine. 2010;28(46):7420–22. doi:10.1016/j.vaccine.2010.08.095.
   PubMed Web of Science ®Google Scholar
• Status of Vaccine Research and Development of Universal Influenza Vaccine. Prepared for WHO PD-VAC. In: WHO; 2014.
   Google Scholar
• Krammer F, García-Sastre A, Palese P. Is it possible to develop a “universal” influenza virus vaccine? Toward a universal influenza virus vaccine: potential target antigens and critical aspects for vaccine development. Cold Spring Harb Perspect Biol. 2017;a028845. doi:10.1101/cshperspect.a028845.
   Web of Science ®Google Scholar
• Erbelding EJ, Post DJ, Stemmy EJ, Roberts PC, Augustine AD, Ferguson S, Paules CI, Graham BS, Fauci AS. A universal influenza vaccine: the strategic plan for the National Institute of Allergy and Infectious Diseases. J Infect Dis. 2018;218(3):347–54. doi:10.1093/infdis/jiy103.
   PubMed Web of Science ®Google Scholar
• Egorov AY. The challenges of creating a universal influenza vaccine. MIR J. 2016;3(1). doi:10.18527/2500-2236-2016-3-1-31-41.
   Google Scholar
• Pica N, Palese P. Toward a universal influenza virus vaccine: prospects and challenges. Annu Rev Med. 2013;64:189–202. doi:10.1146/annurev-med-120611-145115.
   PubMed Web of Science ®Google Scholar
• Ohmit SE, Thompson MG, Petrie JG, Thaker SN, Jackson ML, Belongia EA, Zimmerman RK, Gaglani M, Lamerato L, Spencer SM, et al. Influenza vaccine effectiveness in the 2011–2012 season: protection against each circulating virus and the effect of prior vaccination on estimates. Clin Infect Dis. 2014;58(3):319–27. doi:10.1093/cid/cit736.
   PubMed Web of Science ®Google Scholar
• McLean HQ, Thompson MG, Sundaram ME, Kieke BA, Gaglani M, Murthy K, Piedra PA, Zimmerman RK, Nowalk MP, Raviotta JM. Influenza vaccine effectiveness in the United States during 2012–2013: variable protection by age and virus type. J Infect Dis. 2015;211(10):1529–40.
   PubMed Web of Science ®Google Scholar
• Gaglani M, Pruszynski J, Murthy K, Clipper L, Robertson A, Reis M, Chung JR, Piedra PA, Avadhanula V, Nowalk MP. Influenza vaccine effectiveness against 2009 pandemic influenza A (H1N1) virus differed by vaccine type during 2013–2014 in the United States. J Infect Dis. 2016;213(10):1546–56. doi:10.1093/infdis/jiv577.
   PubMed Web of Science ®Google Scholar
• Zimmerman RK, Nowalk MP, Chung J, Jackson ML, Jackson LA, Petrie JG, Monto AS, McLean HQ, Belongia EA, Gaglani M. 2014–2015 influenza vaccine effectiveness in the United States by vaccine type. Clin Infect Dis. 2016;63(12):1564–73. doi:10.1093/cid/ciw635.
   Web of Science ®Google Scholar
• Jackson ML, Chung JR, Jackson LA, Phillips CH, Benoit J, Monto AS, Martin ET, Belongia EA, McLean HQ, Gaglani M, et al. Influenza vaccine effectiveness in the United States — 2015/16 season. N Engl J Med. 2017;377:534–43. doi:10.1056/NEJMoa1700153.
   Web of Science ®Google Scholar
• Grefenstette JJ, Brown ST, Rosenfeld R, DePasse J, Stone NT, Cooley PC, Wheaton WD, Fyshe A, Galloway DD, Sriram A, et al. FRED (a Framework for Reconstructing Epidemic Dynamics): an open-source software system for modeling infectious diseases and control strategies using census-based populations. BMC Public Health. 2013;13:940. doi:10.1186/1471-2458-13-940.
   PubMed Web of Science ®Google Scholar
• Depasse JV, Nowalk MP, Smith KJ, Raviotta JM, Shim E, Zimmerman RK, Brown ST. Does cost-effectiveness of influenza vaccine choice vary across the U.S.? An agent based modeling study. Vaccine. 2017;35:3974–81. doi:10.1016/j.vaccine.2017.05.093.
   PubMed Web of Science ®Google Scholar
• DePasse J, Smith KJ, Raviotta JM, Shim E, Nowalk MP, Zimmerman RK, Brown ST. Does choice of influenza vaccine type change disease burden and cost-effectiveness in the United States? An agent-based modeling study. Am J Epidemiol. 2017;185(9):822–31. doi:10.1093/aje/kww229.
   PubMed Web of Science ®Google Scholar
• Raviotta JM, Smith KJ, DePasse J, Brown ST, Shim E, Nowalk MP, Zimmerman RK. Cost‐effectiveness and public health effect of influenza vaccine strategies for US elderly adults. J Am Geriatr Soc. 2016;64(10):2126–31. doi:10.1111/jgs.14323.
   PubMed Web of Science ®Google Scholar
• Lee BY, Tai JH, McGlone SM, Bailey RR, Wateska AR, Zimmer SM, Zimmerman RK, Wagner MM. The potential economic value of a ‘universal’(multi‐year) influenza vaccine. Influenza Other Respi Viruses. 2012;6(3):167–75. doi:10.1111/j.1750-2659.2011.00288.x.
   PubMed Web of Science ®Google Scholar
• Patterns of Metropolitan and Micropolitan Population Change: 2000 to 2010. [accessed 2018 Feb 15]. https://www.census.gov/library/visualizations/2012/dec/c2010sr-01-pyramid.html
   Google Scholar
• Longini IM Jr., Halloran ME, Nizam A, Yang Y. Containing pandemic influenza with antiviral agents. Am J Epidemiol. 2004;159(7):623–33. doi:10.1093/aje/kwh092.
   PubMed Web of Science ®Google Scholar
• Ferguson NM, Cummings DA, Cauchemez S, Fraser C, Riley S, Meeyai A, Iamsirithaworn S, Burke DS. Strategies for containing an emerging influenza pandemic in Southeast Asia. Nature. 2005;437(7056):209–14. doi:10.1038/nature04017.
   PubMed Web of Science ®Google Scholar
• Elveback LR, Fox JP, Ackerman E, Langworthy A, Boyd M, Gatewood L. An influenza simulation model for immunization studies. Am J Epidemiol. 1976;103(2):152–65. doi:10.1093/oxfordjournals.aje.a112213.
   PubMed Web of Science ®Google Scholar
• Ferguson NM, Cummings DA, Fraser C, Cajka JC, Cooley PC, Burke DS. Strategies for mitigating an influenza pandemic. Nature. 2006;442(7101):448–52. doi:10.1038/nature04795.
   PubMed Web of Science ®Google Scholar
• Germann TC, Kadau K, Longini IM, Macken CA. Mitigation strategies for pandemic influenza in the United States. Proc Natl Acad Sci U S A. 2006;103(15):5935–40. doi:10.1073/pnas.0601266103.
   PubMed Web of Science ®Google Scholar
• Halloran ME, Ferguson NM, Eubank S, Longini IM Jr., Cummings DA, Lewis B, Xu S, Fraser C, Vullikanti A, Germann TC, et al. Modeling targeted layered containment of an influenza pandemic in the United States. Proc Natl Acad Sci U S A. 2008;105(12):4639–44. doi:10.1073/pnas.0706849105.
   PubMed Web of Science ®Google Scholar
• Cooley P, Brown S, Cajka J, Chasteen B, Ganapathi L, Grefenstette J, Hollingsworth CR, Lee BY, Levine B, Wheaton WD, et al. The role of subway travel in an influenza epidemic: a New York City simulation. J Urban Health. 2011;88(5):982–95. doi:10.1007/s11524-011-9603-4.
   PubMed Web of Science ®Google Scholar
• Cooley P, Lee BY, Brown S, Cajka J, Chasteen B, Ganapathi L, Stark JH, Wheaton WD, Wagener DK, Burke DS. Protecting health care workers: a pandemic simulation based on Allegheny County. Influenza Other Respir Viruses. 2010;4(2):61–72. doi:10.1111/j.1750-2659.2009.00122.x.
   PubMed Web of Science ®Google Scholar
• Molinari NA, Ortega-Sanchez IR, Messonnier ML, Thompson WW, Wortley PM, Weintraub E, Bridges CB. The annual impact of seasonal influenza in the US: measuring disease burden and costs. Vaccine. 2007;25(27):5086–96. doi:10.1016/j.vaccine.2007.03.046.
   PubMed Web of Science ®Google Scholar
• FluVax View. [accessed 2018 Feb 15]. http://www.cdc.gov/flu/fluvaxview/index.htm.
   Google Scholar
• Biscani F, Izzo D, Martens M: esa/pagmo2: pagmo 2.6 (Version v2.6). 2017.
   Google Scholar